In January 2016, the NHS National Screening Committee (NSC) recommended that the Cervical Screening Programme should replace cytological screening with the molecular HPV test as the primary form of screening. It is expected that this molecular HPV screening test will be rolled-out nationally by December 2019. This is a positive move to a more accurate test, which could prevent around 600 cancers a year.
InterSystems provides the information engines that power some of the world's most important applications. In healthcare, finance, government, and other sectors where lives and livelihoods are at stake, InterSystems has been a strategic technology provider since 1978. InterSystems is a privately held company headquartered in Cambridge, Massachusetts...
Learn more »
Holiday Inn, Kensington Forum, 97 Cromwell Road, London SW7 4DN
15 November 2018
The Waldorf Hilton, Aldwych, London WC2B 4DD
20 November 2018
22-23 November 2018
Royal Air Force Museum, Hendon
16 May 2019
The Atrium Conference Centre, Sheffield Hallam University
5-6 June 2019
High-throughput HPV testing: NHSCSP approval secured
Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.
Don't miss out on the latest news affecting UK Pathology Services, Biomedical Scientists and Medical Laboratory Professionals. Register FREE for your regular copy of Pathology In Practice now, and enjoy FREE access to feature article content and to the digital version of Pathology In Practice along with regular news delivered to your inbox.